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We evaluated seropositivity to swine and human H1 influenza viruses in 74 swine farm owners, employ-
ees, their family members, and veterinarians in rural south-central Wisconsin, compared with 114 urban
Milwaukee, Wisconsin, residents. The number of swine farm participants with positive serum hemaggluti-
nation-inhibition (HI) antibody titers >40 to swine influenza viruses (17/74) was significantly higher
(p<0.001) than the number of seropositive urban control samples (1/114). The geometric mean serum HI
antibody titers to swine influenza viruses were also significantly higher (p<0.001) among the farm partici-
pants. Swine virus seropositivity was significantly (p<0.05) associated with being a farm owner or a farm
family member, living on a farm, or entering the swine barn >4 days/week. Because pigs can play a role in
generating genetically novel influenza viruses, swine farmers may represent an important sentinel popula-
tion to evaluate the emergence of new pandemic influenza viruses.
nfections with influenza viruses that circulate within the
human population are a common and important cause of
respiratory disease in people and result in an average of
approximately 20,000 deaths and 114,000 hospitalizations per
year in the United States alone (1–3). Influenza A viruses also
infect animals of a wide variety of other species. In particular,
influenza is a common and economically important cause of
respiratory disease in pigs (4,5); subclinically infected wild
waterfowl provide a global reservoir of influenza A viruses of
all 15 hemagglutinin (HA) and 9 neuraminidase (NA) sub-
types (6,7). 
The occurrence of H5N1 and H9N2 virus infections
among people in Asia in 1997–1999 (8,9) highlighted the
potential for avian influenza viruses to cross species barriers to
infect humans, but direct avian-to-human transmission of
influenza viruses is a rare event. In contrast, the species barrier
for transmission of influenza viruses between people and pigs
appears to be less stringent, and influenza virus infections in
pigs pose important public health concerns at two levels. First,
because respiratory tract epithelial cells in pigs contain the
sialic acid receptors preferred by both avian (α 2,3-N-acetyl-
neuraminic acid-galactose) and human (α 2,6-N-acetyl-
neuraminic acid-galactose) influenza viruses (10), pigs are
postulated to serve as the “mixing vessel” hosts in which reas-
sortment between avian and human viruses can generate
genetically novel viruses with pandemic potential (7,11,12).
Reassortment between human and avian influenza viruses pro-
duced the 1957 and 1968 pandemic viruses (7).  More recently,
human-avian reassortant viruses have been isolated from pigs
in Europe and, thereafter, from children in the Netherlands
(13,14). 
Zoonotic infections of humans with swine influenza
viruses, first confirmed by isolation of swine influenza viruses
from both pigs and their caretaker on a farm in southern Wis-
consin in November 1976 (4), have been diagnosed in the
United States, Europe, New Zealand, and Asia (15). However,
the total number of zoonotic infections that have been
described is relatively small compared to the number of people
worldwide involved directly or indirectly in swine farming.
Swine farm workers are likely to be routinely exposed to and
infected with swine influenza viruses, but only a small per-
centage of those zoonotic infections are documented. Zoonotic
infections may be recognized if information regarding contact
with sick pigs is specifically communicated to physicians, if a
patient is hospitalized or dies, or if virus isolation is pursued
and yields a virus that is antigenically atypical. In most cases,
however, swine influenza virus infections in people may not
be clinically distinguishable from routine human influenza
virus infections. We developed this study to serologically
assess the relative level of exposure to classical H1 swine
influenza viruses among people involved in swine farming.
Methods
Study Population and Design
Names and contact information for swine farmers living in
rural areas of south-central Wisconsin were provided by area
swine veterinarians. We contacted these farmers initially by
telephone and then, if they were interested in participating, one
of the study directors met with them to explain the project’s
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objectives and procedures. To take part in the study, persons
were required to allow home health nurses to collect two blood
samples for influenza virus serologic testing and to complete a
questionnaire regarding their general health and the nature of
their contact with pigs.  Participation was also extended to
other employees on the farm, spouses and children >7 years of
age, and farm veterinarians. A total of 79 participants were ini-
tially enrolled, including 76 persons from 22 farms, as well as
3 farm veterinarians. All participants who completed the study
were compensated by payment of a $100 honorarium.
We chose the time period of this study to correspond with
the seasonality of swine influenza. In the northern midwestern
United States, swine influenza activity is maximal in the late
fall and winter (16). Home health nurses visited each partici-
pant to administer the study questionnaire, collect an initial
preseason blood sample in September 1996, and again to col-
lect a postseason blood sample in April 1997. A total of 114
control serum samples were obtained from a serum bank at the
Wisconsin State Laboratory of Hygiene. These samples had
been submitted for routine serologic testing from residents of
urban Milwaukee, Wisconsin, between August 30, 1996, and
March 13, 1997. Because the people from whom control sera
were obtained were not specifically enrolled in our study, con-
tacting these persons to gather additional information regard-
ing their health status or activities was neither possible nor
ethically appropriate. The use of human participants and con-
trol human serum samples in this study was approved by the
Human Participant Committees of both the University of Wis-
consin-Madison and the Centers for Disease Control and Pre-
vention.
Questionnaire Topics
Farm participants were questioned as to their age and sex,
their overall health, the nature of their contact with swine, and
their influenza virus vaccination history. The specific ques-
tions asked of each participant are listed in the questionnaire
(Figure).
Laboratory Procedures
Each participant was assigned an ID number so that labo-
ratory samples could be assayed without knowledge of per-
sonal identifier information. The human serum samples were
treated with receptor-destroying enzyme (Denka Seiken Co.,
Ltd., Tokyo, Japan) at 37°C for 18 h to eliminate nonspecific
inhibitors of hemagglutination, after which the samples were
tested for HA-specific antibodies using a standard hemaggluti-
nation-inhibition (HI) assay (17). The following strains of
human and classical swine influenza A viruses were employed
as antigens: A/Johannesburg/82/96 (A/JOH; human H1N1), A/
Nanchang/933/95 (A/NAN; human H3N2), A/Nebraska/01/92
(A/NEB; zoonotic human isolate of swine H1N1 influenza
virus), and A/Swine/Indiana/1726/88 (Sw/IND; swine H1N1).
Control sera included sheep anti-human H1 and anti-human
H3 subtype-specific sera, ferret anti-A/NEB, and normal sheep
serum. Each human serum sample was also assayed without
added viral antigen (serum-only control) in parallel with the
virus-specific assays. All HI assays were run simultaneously,
and HI titers were defined as the reciprocal of the highest dilu-
tion of serum that inhibited virus-induced hemagglutination of
a 0.5% solution of chicken red blood cells. To calculate geo-
metric mean titers (GMTs) for individual cohorts, we included
values for virus-specific titers only if they were greater than
the corresponding serum-only control values. Fourfold rises in
titer were examined for the study participants by comparing
their pre and postseason serum antibody titers.
Statistical Analyses
The numbers of sera with an HI titer >40 to either swine
virus were compared among the preseason farm participant
samples versus the urban control samples by chi-square analy-
sis. The GMTs of the samples from preseason farm partici-
pants were compared to the GMTs of the urban control sera by
using Wilcoxon rank sum analysis with normal approximation.
Figure. Questionnaire administered to swine farm participants in this
study.RESEARCH
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We also evaluated associations between preseason seropositiv-
ity to swine influenza viruses at HI titers >40 or >80 among
the farm participants and specific aspects of swine exposure or
other variables. These associations were then examined for
statistical significance by chi-square or two-sided Fisher’s
exact analyses. Multivariate analysis was not done because of
the small numbers of participants with elevated preseason
titers to swine influenza viruses (17 participants with titers
>40; 11 participants with titers >80).
Results
Seventy-nine swine farming participants were initially
enrolled, including 20 farm owners (ages 28–59 years), 14
spouses of farm owners (34–57 years), 12 children of farm
owners (7–21 years), 21 farm employees (19–43 years), 9
spouses of farm employees (21–39 years), and 3 veterinarians
(29–54 years). In total, the farm participants included 44 males
of median age 37 (range 13–59 years) and 35 females of
median age 34 (range 7–57 years). Of these participants, two
people moved out of the area during the study and did not par-
ticipate further, and three people chose to withdraw from the
study before their second blood samples were collected. The
preseason samples from these five participants were not
included in the analyses. Two participants (both with elevated
titers to swine viruses) did not complete the questionnaire.
Serologic data from these two participants were included in
the comparison of preseason titers of farm participants versus
controls but could not be used to assess variables associated
with seropositivity to swine viruses. The control sera were
from 54 males of median age 32 (range 2–58 years) and 60
females of median age 34 (range 4–54 years).
To interpret the HI titers as showing differences in expo-
sure to swine versus human influenza viruses, we first had to
demonstrate that no serologic cross-reactivity in HI assays
between the human and swine reference strains existed. We
compared HI titers by using virus-specific sheep and ferret ref-
erence sera (Table 1) and clearly showed no serologic cross-
reactivity in HI assays between the human H1N1, human
H3N2, and swine H1N1 viruses. The HI titers to homologous
viruses were 320–640, whereas titers to heterologous viruses
(H1 vs. H3 or human H1 vs. swine H1) were only 5–10.
The preseason serum samples from 17/74 farm participants
had HI titers >40 (titer range 40–160) against either A/NEB or
Sw/IND; 15/17 were seropositive to both swine viruses. These
participants included seven farm owners (range 41–55 years),
seven family members of farm owners (range 7–54 years), a
33-year-old farm employee, a 38-year-old family member of a
farm employee, and a 43-year-old veterinarian. In contrast,
only 1/114 of the urban control serum samples (from a 41-
year-old) had a positive HI titer against a swine virus (HI
titer=40 against only A/NEB). The difference in the number of
seropositive samples between the farm participant and urban
control cohorts was statistically significant (p<0.001). Simi-
larly, the GMTs of the preseason serum samples from the farm
participants to both swine-lineage viruses (A/NEB and Sw/
IND) were significantly higher (p<0.001) than the GMTs of
the samples from the urban control participants (13.2 vs. 5.1
and 15.7 vs. 5.4, respectively). In contrast, the farm partici-
pants’ GMTs to the reference human H1 (A/JOH) and H3 (A/
NAN) viruses were not significantly different from those of
the urban control samples (Table 2).
Only three farm participants demonstrated fourfold rises in
titer to either of the swine viruses. These rises were not associ-
ated with illness in either the human participants or the pigs on
their farms.
Each of the variables on the questionnaire (Figure) was
investigated for association with preseason sample seroposi-
tivity to Sw/IND at HI titers >40 or >80, A/NEB at HI titers
>40 or >80, and either swine virus at HI titers >40 or >80. The
variables associated with seropositivity to either swine virus at
HI titers >40 or >80 and the statistical strength of those associ-
ations are shown in Table 3. (Results for seropositivity to each
individual swine virus are not shown but were consistent with
the summary statistics presented in Table 3.) Being a farm
owner, being part of a farm family (a farm owner or a farm
owner’s family member), living on a swine farm, and going
into a swine barn >4 days/week were all associated with serop-
ositivity to swine influenza viruses. Beyond these factors of
pig contact, being >50 years of age (but not >36 years of age,
the median age of the farm participants in the study) was asso-
ciated with swine virus seropositivity; having received the
swine flu vaccine in 1976–77 or having ever received any
influenza virus vaccine was also associated with swine virus
seropositivity. (All four persons who received the swine influ-
enza vaccine also reported having received other influenza
virus vaccines.)
Discussion
Although zoonotic infections with swine influenza viruses
have been documented previously (4,15), the results of the
present study strongly support the hypothesis that people asso-
ciated with swine production are infected with swine influenza
viruses more regularly than the small number of zoonotic
infections in the literature would suggest. Previous studies by
Kluska et al. (18), Woods et al. (19), and Schnurrenberger et
al. (20) in the 1960s suggested increased rates of infection
among persons in contact with pigs or working with swine
influenza viruses. In this study, we specifically associated fac-
tors related to a person’s degree of contact with pigs to serop-
ositivity to swine viruses. The number of hours per day spent
in the barn was not a factor of significance, suggesting that the
overall frequency of pig contact is a more important consider-
ation than the length of contact at any one time. This lack of
significance is consistent with the fact that influenza virus
infections in pigs occur sporadically, and pigs generally only
shed virus for approximately 7 days after infection (21). Dur-
ing the course of this study, pigs on only one farm were
reported to exhibit signs of influenza-like illness. Influenza
viruses were not isolated from nasal swab samples collected
from these pigs.Emerging Infectious Diseases  •  Vol. 8, No. 8, August 2002 817
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Two factors not directly related to swine contact were also
statistically associated with seropositivity to swine viruses in
our study. First, being >50 years of age was associated with
swine virus seropositivity. In an earlier study, Schnurrenberger
et al. (20) collected samples in 1966 from abattoir workers,
pork producers, swine exhibitors at a state fair, and veterinari-
ans; they also found an association between age and seroposi-
tivity to a classical H1N1 swine influenza virus. In that study,
the major impact of age was apparent for people born before
1920, suggesting an effect from exposure to the swine-like
1918 pandemic influenza virus (22–24). We could not fully
separate the effects of age and exposure over time to swine.
All of the participants >50 years of age were farm owners or
farm family members. However, several factors indicate that,
although age may play a role in seropositivity to swine viruses,
exposure to swine is a more dominant factor. Farmers and their
family members were significantly more likely than employ-
ees and their family members to have elevated titers to swine
viruses; farmers and their families were also more likely to
have exposure to swine and to be exposed over a longer period
of time. Specifically, 88% of the farm owners and their fami-
lies lived on the swine farm, compared to 7% of the employees
and their families. Furthermore, of the farm owners and their
families who lived on the farm, 77% had lived there >11 years.
Farm owners had significantly more years in swine production
than their employees (Mantel-Haenszel chi-square test for
trend, p<0.001). Among younger study participants (<50 years
of age), 21% and 18% of the farm family members had titers
of >40 and >80 to swine viruses, respectively, compared to
only 7% and 4% for employees and their family members.
Although these differences among the younger participants
were not statistically significant (p=0.09 to 0.14), they are con-
sistent with the pattern of elevated titers seen among those
with a higher level of exposure to pigs. Finally, our control
population was of the same overall age distribution as our farm
participants, yet only a single 41-year-old person among these
controls was seropositive to a swine virus.
A second factor unrelated to swine contact significantly
associated with swine virus seropositivity was having received
either the swine influenza virus human vaccine in 1976–77 or
ever having received any human influenza virus vaccine.
However, vaccination status alone most likely did not deter-
mine seropositivity to swine viruses among our farm partici-
pants. Vaccination was only associated with seropositivity at a
titer >40, but not at >80. Although we do not have historical
data for our urban control samples, we have no a priori reason
to suspect that these people would have had substantially dif-
ferent vaccination histories. However, only 1/114 of these par-
ticipants demonstrated a titer >40 to a swine virus. Likewise,
the proportions of employees and their family members who
received the swine influenza vaccine (4%) or other influenza
vaccines (32%) were not significantly different from the pro-
portions of farm family members who received the swine
influenza vaccine (6%) or other influenza vaccine (22%), but
farm family members were significantly more likely to have
elevated titers to swine viruses. Regarding having received the
1976–77 swine influenza vaccine, antibodies produced against
that vaccine would not likely be present at detectable levels 20
years later. However, studies have shown that vaccination with
more recent human influenza A (H1N1) viruses can boost
Table 2. Geometric mean titers of preseason serum samples from farm participants and urban control serum samples
Reference influenza A viruses
Participants
A/Johannesburg/82/96 
(A/JOH) (human H1N1 virus)
A/Nanchang/933/95
(A/NAN)
(human H3N2 virus)
A/Nebraska/01/92
(A/NEB)
(zoonotic swine H1N1 virus)
A/Swine/Indiana/1726/88
(Sw/IND) (swine H1N1 virus)
Farm participants 15.3 8.6 13.2a 15.7a
Urban control participants 14.2 8.0 5.1 5.4
ap>0.0001 (Wilcoxon rank sum analysis with normal approximation).
Table 1. Hemagglutination-inhibition titers of control sera to reference virus strains used in this study
Reference influenza A viruses
Control serum
A/Johannesburg/82/96 
(A/JOH)
(human H1N1 virus)
A/Nanchang/933/95
(A/NAN)
(human H3N2 virus)
A/Nebraska/01/92
(A/NEB)
(zoonotic swine H1N1 virus)
A/Swine/Indiana/1726/88
(Sw/IND)
(swine H1N1 virus)
Sheep anti-human H1N1a 640 10 5 5
Sheep anti-human H3N2b 53 2 0 5 5
Ferret anti-A/NEB 5 10 640 320
Ferret anti-swine H1N1c 5 10 320 640
Normal sheep serum 10 10 5 5
aProduced by immunization of sheep with A/Taiwan/1/86 and A/Texas/36/91 (H1N1).
bProduced by immunization of sheep with A/Shangdong/9/93, A/Johannesburg/33/94, and A/Nanchang/933/95 (H3N2).
cProduced by immunization of ferrets against A/Swine/Wisconsin/01/88 (H1N1).RESEARCH
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titers to swine-like viruses in those previously exposed (25).
Therefore, the statistical association between seropositivity to
swine viruses and vaccination likely reflects a vaccine-induced
boosting of antibody titers in persons previously exposed to a
swine influenza virus. Because of the overall low numbers of
participants with elevated titers to swine viruses, we were not
able to perform meaningful multivariate analysis of the data to
definitively segregate the effect of vaccination history (or age)
from other variables.
Because a relatively small number of zoonotic swine influ-
enza virus infections have been documented by virus isolation,
whether infections with swine influenza viruses are clinically
different than infections with routine human influenza viruses
remains unclear. Our data suggest that aggressively pursuing
virus isolation when people involved in swine farming have
influenza-like illnesses would be valuable. In this way, retro-
spective studies of the clinical appearance of a larger number
of zoonotic swine influenza cases may be possible. 
Our findings suggest a second issue. Pigs may serve as
hosts for the adaptation of avian viruses to replication in mam-
malian species (26). In addition, pigs are clearly recognized as
hosts in which genetic reassortment between human and avian
viruses can produce novel strains of pandemic potential
(7,11,12). While this concern has historically been thought to
be most important in the “Asia epicenter” (12,27), avian H1N1
viruses have spread widely within the swine population of
northern Europe since 1979 (7,28–31), avian H4N6 viruses
were isolated from pigs in Canada in 1999 (32), and human/
swine/avian reassortant H3N2 (33–35) and H1N2 (36,37)
viruses have spread widely within the swine population of the
United States since 1998. Given the apparent frequency with
which swine farm workers in our study were exposed to influ-
enza viruses from pigs, more closely monitoring such persons
as potential sentinels for the emergence of novel influenza
viruses from the swine populations of developed countries
with extensive swine-raising industries may be prudent.
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